Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • School of Medicine (MU)
    • Department of Medicine (MU)
    • Division of Hospital Medicine (MU)
    • 2017-present: American journal of hospital medicine
    • American journal of hospital medicine, volume 4, issue 3 (2020 July-September)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • School of Medicine (MU)
    • Department of Medicine (MU)
    • Division of Hospital Medicine (MU)
    • 2017-present: American journal of hospital medicine
    • American journal of hospital medicine, volume 4, issue 3 (2020 July-September)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Oral versus Intravenous Antimicrobials for Serious Infections

    Rojas-Moreno, Christian
    View/Open
    [PDF] IDcornerOralVersusIntravenous.pdf (122.6Kb)
    Date
    2020-07
    Format
    Article
    Metadata
    [+] Show full item record
    Abstract
    "There is a common belief among physicians and patients, that “intravenous (IV) antibiotics are better than oral antibiotics, they are stronger, they work faster”. However, for many infectious conditions, including serious infections, there is no conclusive evidence that IV antibiotics are superior to oral antibiotics. The bacteria also do not know how the antibiotic gets to the infection site 1. Additionally, IV antibiotics are not a panacea without downsides. IV antibiotics are associated with prolonged hospital stays; they may be associated with more adverse events and higher costs. The line needed for outpatient parenteral antimicrobial therapy (OPAT) can complicate in 22% of cases, with almost half of them requiring emergency department visit or hospital admission 2."
    URI
    https://doi.org/10.24150/ajhm/2020.018
    https://hdl.handle.net/10355/82565
    Part of
    ID Corner
    Part of
    American journal of hospital medicine, volume 4, issue 3 (2020 July-September)
    Citation
    Am J Hosp Med 2020 July;4(3):2020.18 https://doi.org/10.24150/ajhm/2020.018
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • American journal of hospital medicine, volume 4, issue 3 (2020 July-September)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems